Grifols to issue $1.0 bln bond to fund Talecris buy

MADRID, July 9 (BestGrowthStock) – Spanish haemoderivatives maker
Grifols (GRLS.MC: ) will likely fund part of the purchase of its
U.S. rival Talecris (TLCR.O: ) with a high-yield bond issue worth
$1.0 billion, a source close to the situation said on Friday.

Grifols has bid $3.4 billion for Talecris. [ID:nLDE65K1C4]

“Under a provisional framework to obtain $4.5 billion in
financing we are considering a high-yield bond issue worth $1.0
billion,” the source said, adding that details were not
finalised.

Credit agencies Moody’s and Standard and Poor’s are expected
to assign Grifols ratings in the coming days, he added.

(Reporting by Jose Elias Rodriguez; Editing by Erica
Billingham)

Grifols to issue $1.0 bln bond to fund Talecris buy